Neumora logo

Neumora

Pioneering a new era of medicines for brain diseases

111 employees · est. 2020 · Watertown, United States

VS
Psy Therapeutics logo

Psy Therapeutics

Creating new futures in central nervous system (CNS) treatment and care.

11 employees · est. 2012 · Boston, United States

Psy Therapeutics is the older company (2020 vs 2012); Neumora is the larger of the two.

Side-by-Side Comparison

Neumora Psy Therapeutics
Founded
2020 2012 older
Headquarters
Watertown, United States Boston, United States
Employees
111 larger 11
Industry
Biotechnology, Health Care Biotechnology, Health Care, Health and Wellness
Funding Stage
Series B Seed
Total Funding
$612.00M $3.97M
Funding Rounds
4 3
Services
Development of precision medicines for brain diseases, Drug pipeline targeting novel mechanisms of action, Integration of translational, clinical, and computational tools Discovering and developing novel medicines for CNS disorders, Advancing therapeutic pipeline for neuropsychiatric care, Drug discovery and development, Translational approach in neuroscience
Target Customers
Patients with brain diseases, Medical professionals in neurology and psychiatry, Healthcare providers focused on CNS disorders Patients with anxiety disorders, Patients with major depressive disorder, Patients with dementia, Healthcare providers, Research institutions focused on neuropsychiatric disorders
Taxonomy
Brain DiseasesNeuroscienceNeuropsychiatric DisordersNeurodegenerative DiseasesPrecision NeuroscienceNovel Mechanisms Of Action +9 CNS TreatmentNeuropsychiatric DisordersNeurodegenerative DisordersNovel Small MoleculesPlatform TechnologiesClinical And Preclinical Science +8
Website
neumoratx.com psythx.com
Neumora logo

About Neumora

Neumora, founded in 2020 in the United States, is a pioneering company in the Biotechnology and Health Care industries, with a mission to redefine treatment methodologies for brain diseases. Operating under the slogan, "Pioneering a new era of medicines for brain diseases," Neumora addresses a criti...

Psy Therapeutics logo

About Psy Therapeutics

Psy Therapeutics is at the forefront of biotechnological innovation, aiming to transform treatment landscapes for neuropsychiatric and neurodegenerative disorders. Established in 2012, their mission encapsulates creating "new futures in central nervous system (CNS) treatment and care." The company'...

Also comparing in this category

We will tell you when either one moves

BounceWatch watches Neumora and Psy Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.

Get notified when Neumora or Psy Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Frequently Asked Questions

Neumora — Pioneering a new era of medicines for brain diseases. Psy Therapeutics — Creating new futures in central nervous system (CNS) treatment and care. . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Neumora has raised $612.00M while Psy Therapeutics has raised $3.97M.
Neumora and Psy Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Neumora with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Neumora on 9 Jun 2026, and Psy Therapeutics on 27 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes